Sanjay Chandran has been named CEO of InnoMed Technologies (Boca Raton, Florida), a manufacturer of products to treat sleep and respiratory disorders. Chandran succeeds Patrick Karem. Chandran was with GE Healthcare from 1997 to September 2004, where he served as OEM business manager.

Patricia Goldsmith has joined National Comprehensive Cancer Network (NCCN; Jenkintown, Pennsylvania) as senior vice president for business development, public affairs and policy. Goldsmith formerly served as vice president for institutional development, public affairs and marketing at the H. Lee Moffitt Cancer Center & Research Institute, one of the NCCN's member institutions. An alliance of 19 of the world's leading cancer centers, the NCCN develops, updates and disseminates a complete library of clinical practice guidelines that are the standard for clinical policy in oncology.

Jack Huttner has been elected to a two-year term as chairman of the board of the New York Biotechnology Association (NYBA; New York). Huttner is vice president of corporate communications and public affairs at Genencor International, and brings more than 15 years of management experience to the board. NYBA's mission is to aid and promote the growth of New York biotech companies, and to help New York State realize its potential as a global center for the biotech industry.

• Varian Medical Systems (Palo Alto, California), a maker of integrated cancer therapy systems, X-ray tubes and flat-panel digital subsystems for imaging, reported three new management appointments. Timothy Guertin, executive vice president, has been named chief operating officer. Guertin joined the company 29 years ago and has been serving since 1999 as president of Oncology Systems, Varian's largest business segment. Dow Wilson has been appointed corporate vice president and president, Oncology Systems. Wilson previously was CEO of GE Healthcare-Information Technologies. Elisha Finney, corporate vice president and CFO, has been promoted to senior vice president.

No Comments